SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bafna Pharmaceuticals zooms on getting UK-MHRA approval for packaging lines

04 May 2021 Evaluate

Bafna Pharmaceuticals is currently trading at Rs. 135.15, up by 6.40 points or 4.97% from its previous closing of Rs. 128.75 on the BSE.

The scrip opened at Rs. 135.15 and has touched a high and low of Rs. 135.15 and Rs. 135.15 respectively. So far 4047 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 195.95 on 23-Mar-2021 and a 52 week low of Rs. 10.24 on 27-Jul-2020.

Last one week high and low of the scrip stood at Rs. 137.90 and Rs. 123.80 respectively. The current market cap of the company is Rs. 319.72 crore.

The promoters holding in the company stood at 91.74%, while Non-Institutions held 8.26%.

Bafna Pharmaceuticals has added two fully automated packaging lines to its existing capacity and they have been approved by the UK-MHRA (Medicines and Healthcare products Regulatory Agency) for the United Kingdom and the European Union (EU). This approval will enable the company to increase its output and consequentially generate higher revenue and profits.

Bafna Pharmaceuticals is engaged in the business of manufacturing of finished pharmaceutical formulations.

Bafna Pharma Share Price

145.00 12.40 (9.35%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×